| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $150.6M | — | +41.2% |
| Cost of Revenue | $33.3M | — | +37.1% |
| Gross Profit | $117.2M | — | +42.4% |
| R&D Expense | $44.1M | — | +36.4% |
| SG&A Expense | $92.9M | — | +31.5% |
| Operating Income | -$19.9M | — | +4.0% |
| Pre-tax Income | -$19.3M | — | -8.3% |
| Income Tax | $484K | — | +48.5% |
| Net Income | -$19.8M | — | -9.0% |
| EPS (Basic) | -$0.34 | — | -6.3% |
| EPS (Diluted) | -$0.34 | — | -6.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $104.2M | +14.8% | -8.8% |
| Accounts Receivable | $119.7M | +10.2% | +67.3% |
| Inventory | $62.4M | -1.9% | +4.9% |
| Current Assets | $485.8M | +2.3% | +9.3% |
| Total Assets | $893.3M | -0.0% | -7.5% |
| Current Liabilities | $89.4M | -11.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$12.5M | — | +32.4% |
| Capital Expenditures | $4.0M | — | +104.3% |
| Investing Cash Flow | $10.5M | — | +128.4% |
| Financing Cash Flow | $15.8M | — | +708.7% |
| Free Cash Flow | -$16.5M | — | +19.4% |
| +30.5% |
| Total Liabilities | $222.4M | -6.3% | +10.0% |
| Stockholders' Equity | $670.9M | +2.3% | -12.2% |